Nebula Research & Development LLC Veracyte, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 45,236 shares of VCYT stock, worth $1.38 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
45,236
Previous 46,519
2.76%
Holding current value
$1.38 Million
Previous $1.58 Billion
13.13%
% of portfolio
0.21%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
76.8MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$251 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$238 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$202 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$129 Million1.46% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.08MShares$94.2 Million1.83% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.19B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...